Frontage provides integrated solutions to our clients: Formulation, Product Development, Analytical Testing, from preclinical to clinical drug development, including commercial products.

Frontage’s Bioanalytical Team is highly experienced in developing, qualifying, and validating biomarker assays for Alzheimer's Disease. Our biomarker assay services provide accurate, reliable information for our partners.

Regulated preclinical developmental and reproductive toxicity (DART) studies using mammalian research models are an important step to take before initiating clinical trials. Frontage’s scientists have over 20 years of experience running DART studies with knowledge of accurately estimating test doses, showing formulation stability, and expertise in animal handling. Our labs have the extensive capacity to run many studies, helping our sponsors meet their timelines with uncompromising quality.